Podcast Episode Details
Back to Podcast Episodes
Fewer COVID Vaccine Doses Materialized Last Fall Than The U.S. Government Hoped
Episode 480
Manufacturers can expect to face unforeseen hurdles when they begin to mass-produce a brand new pharmaceutical product, and in a pandemic, there are bound to be supply chain problems as well. But in late 2020, Pfizer was delivering fewer doses than the government expected and then-federal officials told NPR they did not know why.
Published on 4 years, 3 months ago